Midazolam — 10MG/2ML, Injection, carton of 25 × 2 mL vials

Midazolam — 10MG/2ML, Injection, carton of 25 × 2 mL vials

Midazolam is a injection for intramuscular; intravenous use. Midazolam Injection is indicated: intramuscularly or intravenously for preoperative sedation/anxiolysis/amnesia; intravenously as an agent for sedation/anxiolysis/amnesia prior to or during diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography, cardiac catheterization, oncology procedures, radiologic procedures, suture of lacerations and other procedures either alone or in combination with other CNS depressants; intravenously for induction of general anesthesia, before administration of other anesthetic agents. With the use of narcotic premedication, induction of anesthesia can be attained within a relatively narrow dose range and in a short period of time.

• Active ingredient or product type: MIDAZOLAM HYDROCHLORIDE
• Strength/concentration: 10MG/2ML
• Dosage form and route: Injection, Intramuscular; Intravenous
• Exact package presentation: carton of 25 × 2 mL vials
• NDC/item number: 0641-6063-25
• Manufacturer: HIKMA PHARMACEUTICALS USA INC
• Storage/handling: Store at controlled room temperature according to the current product labeling.
• Status: Rx only

Important safety information: WARNINGS Personnel and Equipment for Monitoring and Resuscitation Adults and Pediatrics: Intravenous midazolam has been associated with respiratory depression and respiratory arrest, especially when used for sedation in noncritical care settings.

Refer to the current product labeling for complete indications, preparation or administration instructions, contraindications, warnings, precautions, and storage requirements.